Search
ASGCT 2025: HuidaGene presented preclinical and early clinical data for its CRISPR Cas12 based program for DMD in a Presidential Symposium talk
CEO Alvin Luk and CTO TJ Cradick explain how the company's Cas12 and 13 programs are different than Cas9, and they discuss the DMD...
May 15
Gene therapies expert TJ Cradick previews what to watch for at the 2025 ASGCT Annual Meeting in New Orleans
He discusses the clinical programs, delivery vehicle advances, and safety improvements to watch for this year as the field of cell and...
May 13
The co-founder of the Scientific Citizenship Initiative discusses the importance of scientific communication, and trying to place STEM PhDs into the Mass. State House as full-time policy advisors
In a discussion with gene editing technology expert TJ Cradick, Scientific Citizenship Initiative Co-Founder and Co-Director Daniel...
Jan 22
Gene therapy experts TJ Cradick and Andrew Kernytsky discuss the issues surrounding unintended off-target editing of genetic tools like CRISPR
For this high-tech emerging field within biotech, it is important to get safety right. They discuss the keys to understanding the...
Oct 17, 2024
Gene therapy experts TJ Cradick and Kate Excoffon discuss using AAV gene therapy for cystic fibrosis
Dr. Excoffon describes her academic experience that led her to the field and Spirovant Sciences, discusses interesting data from last...
Oct 3, 2024
Previewing the 2024 ASGCT Annual Meeting in Baltimore with gene editing expert TJ Cradick
TJ Cradick gives us a preview of which abstracts and technologies to watch this year, including the latest in gene editing methods and...
May 7, 2024
.png){kind=logo}
